Details

Written by: admin

Category: Projects

Published: 30 April 2026

Hits: 18

• Lusófona University
• [{"typeDiscriminator":"InternalCollaboratorAssociation","pureId":36210007,"leadCollaborator":true,"organization":{"systemName":"Organization","uuid":"37e0cf22-558c-4af8-99b7-717641a3f596"}},{"typeDiscriminator":"ExternalCollaboratorAssociation","pureId":36210008,"leadCollaborator":false,"externalOrganization":{"systemName":"ExternalOrganization","uuid":"e1a60377-86ae-44cb-be7c-d558d4da33ce"}},{"typeDiscriminator":"ExternalCollaboratorAssociation","pureId":36210009,"leadCollaborator":false,"externalOrganization":{"systemName":"ExternalOrganization","uuid":"18aefbb4-37b2-4342-bcff-2d7d55ef9d75"}},{"typeDiscriminator":"ExternalCollaboratorAssociation","pureId":36210010,"leadCollaborator":false,"externalOrganization":{"systemName":"ExternalOrganization","uuid":"10e404c8-380a-47c8-8d02-2bfeec0a41c4"}},{"typeDiscriminator":"ExternalCollaboratorAssociation","pureId":36210011,"leadCollaborator":false,"externalOrganization":{"systemName":"ExternalOrganization","uuid":"3857b88b-4b17-4f58-86f6-f6a9ce6d45c0"}}]
• [{"typeDiscriminator":"InternalParticipantAssociation","pureId":36210017,"name":{"firstName":"Patrícia Dias Mendonça","lastName":"Rijo"},"role":{"uri":"/dk/atira/pure/upmproject/roles/upmproject/pi","term":{"en_GB":"PI","pt_PT":"PI"}},"associationHidden":false,"person":{"systemName":"Person","uuid":"262d7bec-3bd1-4ce2-abb8-1450bfbd0e6f"},"organizations":[{"systemName":"Organization","uuid":"79a7d58b-ba26-401a-8fb7-d5b5606228b8"}]}]
• • Patrícia Dias Mendonça Rijo
    PI
• • Lusófona University
  • Tampere University Of Technology, Lab. Of Chemistry And Bioengineering
  • National Institute Of Health
  • Tampere University Of Technology, Biomeditech, Lab. Of Biosystems Dynamics
  • Tampere University Of Technology, Biomeditech, Biomaterials Group
• https://research.ulusofona.pt/en/projects/f40c9780-999e-4a34-bbe1-6ea137b049c1
• f40c9780-999e-4a34-bbe1-6ea137b049c1
• The Nipharmin aim is to increase the potency of Nipharmins and to develop Nipharmin-based antibacterial technologies. In this context, the synthesis of new derivatives and further studies for understanding their mechanism of action are necessary. We formed a multidisciplinary team to develop this new family of antibacterials and to investigate their potential in biotechnological applications.
• Past
• 2019-12-31
• 2018-01-01
• Nipharmin
• a new antibacterial scaffold and biological applications